NATION IN BRIEF : WASHINGTON, D.C. : Drugs Seen Prostate Cancer Survival Aid
Advanced prostate cancer patients treated with two drugs live an average of 10 to 15 months longer than those who undergo castration instead, a study shows. The study, reported by European scientists at a meeting of the American Urological Assn. in Washington, confirms similar findings by a National Cancer Institute study in 1989. Castration has been a routine method of treating advanced prostate cancer. The European and U.S. drug studies used two drugs, flutamide and goserelin acetate, which inhibit the biological effects of the male sex hormones.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
